Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

951
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
951
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

46
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Teratogenicity01:07

Teratogenicity

2.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intelligent detection for Polycystic Ovary Syndrome (PCOS): Taxonomy, datasets and detection tools.

Computational and structural biotechnology journal·2025
Same author

A mixed-methods study of the drivers of stunting reduction among children under five in Nigeria, 2008-2018.

The American journal of clinical nutrition·2025
Same author

Hypothermia in preterm infants admitted to low-resource neonatal units in northern Nigeria: an observational study of occurrence and risk factors.

BMC pediatrics·2024
Same author

A clustered randomized control trial to assess feasibility, acceptability, and impact of implementing the birth companion intervention package in Ethiopia, Kenya, and Nigeria: study protocol.

BMC health services research·2023
Same author

Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort study.

Pediatric research·2023
Same author

Audit of emergency obstetric referrals at a tertiary center in Kano.

Annals of African medicine·2023

Related Experiment Video

Updated: Aug 31, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

907

Eclampsia a preventable tragedy: an African overview.

Labaran Dayyabu Aliyu1, Abubakar Saidu Kadas2, Mohammed Abdulsalam1

  • 1Bayero University, Kano, Nigeria.

Journal of Perinatal Medicine
|August 23, 2022
PubMed
Summary

Eclampsia remains a significant threat in Sub-Saharan Africa due to unique risk factors and socioeconomic barriers. Addressing this requires a holistic approach focusing on education, poverty alleviation, and improved healthcare infrastructure for eclampsia management.

Keywords:
Sub-Saharan Africaeclampsiaincidencemortalityprevalenceprevention

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.0K

Related Experiment Videos

Last Updated: Aug 31, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

907
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.0K

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Maternal Health

Background:

  • Eclampsia is a severe multisystemic obstetric complication leading to maternal and fetal morbidity/mortality.
  • While incidence has decreased globally, Sub-Saharan Africa (SSA) faces persistently high rates.
  • Specific risk factors prevalent in SSA include multiple pregnancies, sickle cell disease, extreme reproductive ages, and pre-existing vasculitis.

Purpose of the Study:

  • To analyze the factors contributing to the high incidence and mortality of eclampsia in Sub-Saharan Africa.
  • To identify compounding socioeconomic and healthcare system challenges hindering eclampsia reduction in SSA.
  • To propose comprehensive and cost-effective solutions for mitigating eclampsia in the region.

Main Methods:

  • This study is a review analyzing prevalent factors hindering eclampsia reduction in Sub-Saharan Africa.
  • It critically assesses global risk factors in the context of SSA's specific demographic and socioeconomic landscape.
  • The review synthesizes information to propose actionable, evidence-based interventions.

Main Results:

  • Commonly identified risk factors for eclampsia are exacerbated in SSA by factors like illiteracy, poverty, and limited access to quality prenatal care.
  • Inadequate healthcare infrastructure, poorly trained personnel, and lack of essential medicines further compound the problem.
  • Superstitious beliefs and poor transportation services also contribute to delayed or inadequate medical attention.

Conclusions:

  • A holistic approach is essential to combat eclampsia in SSA, integrating education, poverty alleviation, and improved healthcare services.
  • Enhancing transport, health infrastructure, skilled manpower, and drug supply are critical for effective eclampsia management.
  • Addressing the unique challenges in SSA requires tailored, cost-effective strategies to reduce maternal and fetal mortality from eclampsia.